For example, RIPK3best known for driving necroptosisalso phosphorylates GPX4, promoting its degradation and enhancing ferroptosis in AKI
[16] DPP-4 inhibitors (such as sitagliptin), which enhance incretin activity through a different mechanism Insulin therapy, particularly if oral agents and other injectables are unsuitable Traditional agents like metformin, sulphonylureas, or pioglitazone, depending on individual circumstances NICE guideline NG28 recommends individualised treatment approaches based on HbA1c targets, cardiovascular risk, renal function, and patient preferences
Although high folic acid intake is a concern, the health implications are unclear, and further studies are needed
To date, no FDA safety communication has identified colorectal cancer as a safety signal for GLP-1 receptor agonists